Agenus | Koszty Operacyjne



Operating Expenses Zmiana Data
AbbVie USD 9.61B 6.98B 2025-03
Amgen USD 6.86B 85M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Celldex Therapeutics USD 63.43M 6.23M 2025-03
CSL USD 5.72B 173M 2024-12
Dynavax Technologies USD 91.79M 18.13M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Incyte USD 847.73M 29.46M 2025-03
J&J USD 8.26B 10.37B 2025-03
Jiangsu Hengrui CNY 5.12B 794.72M 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Merck EUR 4.27B 51M 2025-03
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Veracyte USD 113.31M 1.15M 2025-03



Agenus Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.